Recent ARMP Stock Price | ARMP Stock Predictions | |
$2.53 | +216.21% |
$8.00 |
Recent ARMP Analyst Ratings Breakdown, Making ARMP Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 2 | 2 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the ARMP stock predictions from the analysts covering Armata Pharmaceuticals Inc, we have collected all of the individual ARMP stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering ARMP (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ARMP stock predictions may vary widely, another useful metric to consider is the median ARMP stock prediction, which represents the price at which half of the analysts
made ARMP stock predictions that were higher and half made ARMP stock predictions that were lower. This makes for a different take on the ARMP stock predictions out there, as compared to average or mean.
And that median across all the individual ARMP stock predictions was: $8.0 as of 2024-04-24.
The very highest of the ARMP stock predictions for one year price target was $9.0, while the very lowest of the ARMP stock predictions in the analyst group was
$7.0 (with a standard deviation of $1.414). Get the latest Zacks research report on ARMP — FREE
Find out: ARMP next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
R Stock Predictions
ELS Stock Predictions
AGX Stock Predictions
CVBF Stock Predictions
CBIO Stock Predictions
SHG Stock Predictions
ARDX Stock Predictions
ZM Stock Predictions
MGNX Stock Predictions
|
|
Strong Buy (4.00 out of 4) 98th percentile
(ranked higher than approx. 98% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |